Dana Johnson
spokespersonFemale0.0Global Dominance: 0.00%
Dana Johnson is a spokesperson for Revolution Medicines Inc., the company developing daraxonrasib, who has communicated about the drug's availability and the company's plans for expanding access to patients outside of the United States.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dana Johnson, a spokesperson for Revolution Medicines, explained the eligibility for the FDA program.
Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patientsThe Globe and Mail·
Canada· 2026-07-08
Canada· 2026-07-08
